Sildenafil citrate and uteroplacental perfusion in fetal growth restriction
Egyptian Journal of Hospital Medicine [The]. 2018; 71 (4): 2989-2995
en Inglés
| IMEMR
| ID: emr-192557
ABSTRACT
Background:
Severe early-onset fetal growth restriction can lead to a range of adverse outcomes including fetal or neonatal death, neurodisability, and lifelong risks to the health of the affected child. Sildenafil, a phosphodiesterase type 5 inhibitor, potentiates the actions of nitric oxide, which leads to vasodilatation of the uterine vessels and might improve fetal growth in utero
Buscar en Google
Índice:
IMEMR (Mediterraneo Oriental)
Asunto principal:
Perfusión
/
Embarazo
/
Estudios Prospectivos
/
Circulación Placentaria
/
Mujeres Embarazadas
/
Retardo del Crecimiento Fetal
Tipo de estudio:
Ensayo Clínico Controlado
Límite:
Adulto
/
Femenino
/
Humanos
Idioma:
Inglés
Revista:
Egypt. J. Hosp. Med.
Año:
2018
Similares
MEDLINE
...
LILACS
LIS